Esophageal cancer treatment costs by phase of care and treatment modality, 2000-2013.

ABSTRACT:

Background

Detailed cost estimates are not widely available for esophageal cancer. Our study estimates phase-specific costs for esophageal cancer by age, year, histology, stage, and treatment for older patients in the United States and compares these costs within stage and treatment modalities.

Methods

We identified 8061 esophageal cancer patients in the Surveillance, Epidemiology, and End Results-Medicare database for years 1998-2013. Total, cancer-attributable, and patient-liability costs were calculated based on separate phases of care-staging (or surgery), initial, continuing, and terminal. We estimated costs by treatment modality within stage and phase for esophageal adenocarcinoma and squamous cell carcinoma separately. We fit linear regression models using log transfo

SUBMITTER: Tramontano AC 

PROVIDER: S-EPMC6718574 | biostudies-literature | 2019 Sep

REPOSITORIES: biostudies-literature